株価
2.91
毎日の変更
-0.36 -11.01%
毎月
-14.91%
毎年
64.41%
Q1 予測
3.25




負債 変化する 日付
AbbVie USD 1000K 70.48B 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amarin USD 0 0 2025-03
Amgen USD 54.59B 1.62B 2025-09
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Cipla INR 4.38B 231.9M 2025-03
CSL USD 11.96B 219M 2024-12
Cytokinetics USD 1.2B 338.79M 2025-09
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Geron USD 121.92M 73K 2025-09
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Merck USD 41.37B 5.97B 2025-09
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 734M 7M 2025-09
Nektar Therapeutics USD 0 0 2022-06
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12


Esperion Therapeutics 負債 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2026.